Recent News

• 05.28.2026 - BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting
• 05.15.2026 - BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
• 04.17.2026 - BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

Recent Filings

• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.15.2026 - 8-K Current report
• 05.15.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]